| Health Care Equipment & Supplies Industry | Healthcare Sector | - CEO | TWSE Exchange | TW0004198007 ISIN |
| Taiwan Country | - Employees | - Last Dividend | 4 Aug 2022 Last Split | - IPO Date |
S&S Healthcare Holding Ltd., previously known as Swissray Global Healthcare Holding Ltd. until its rebranding in August 2020, is a pioneering entity in the medical imaging sector. Established in 1988, the company has carved a significant niche for itself in the medical technology landscape. With its headquarters firmly based in Taipei, Taiwan, S&S Healthcare engages deeply in the research, development, manufacturing, and distribution of leading-edge medical imaging devices. Its operations span a global scale, including key markets in Taiwan, the United States, and Switzerland, among other international territories. Over the years, the company has earned recognition for its innovative approach towards medical diagnostics, particularly in the realm of digital X-ray systems and bone density analysis.
These state-of-the-art systems are at the forefront of S&S Healthcare Holding Ltd.'s product lineup. Designed with precision and user-friendliness in mind, they cater to an array of diagnostic needs, ensuring high-quality imaging results. The development of these systems emphasizes enhancing diagnostic capabilities while also focusing on patient comfort and safety during imaging procedures.
The company has made significant strides in the field of bone densitometry. These products are developed with the aim to accurately measure bone density, assisting healthcare professionals in diagnosing and treating conditions such as osteoporosis. With a strong focus on research and development, S&S Healthcare ensures that their densitometry solutions stand at the cutting edge, providing reliable and precise measurements that contribute to effective patient care.
Understanding the importance of holistic health assessments, S&S Healthcare has also ventured into the production of body composition assessment products. These tools are essential for evaluating body composition metrics, giving healthcare providers valuable insights into the health status and risks associated with different body composition profiles. The development of these products aligns with the company's mission to offer comprehensive diagnostic solutions that support overall health and well-being.